CIG
CCM Investment Group Portfolio holdings
AUM
$946M
This Quarter Return
-5.8%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$917M
AUM Growth
–
Cap. Flow
+$917M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
54.91%
Holding
208
New
208
Increased
–
Reduced
–
Closed
–
Top Buys
Top Sells
No sells this quarter
Sector Composition
| 1 | Consumer Discretionary | 8.89% |
| 2 | Industrials | 8.72% |
| 3 | Healthcare | 7.95% |
| 4 | Technology | 7.8% |
| 5 | Consumer Staples | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Avantis US Small Cap Value ETF
AVUV
$18.2B
| $95.9M | 10.46% |
+997,536
| New | +$95.9M |
|
2
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $91.8M | 10.02% |
+1,920,984
| New | +$91.8M |
|
3
iShares Core MSCI International Developed Markets ETF
IDEV
$21.2B
| $91.3M | 9.95% |
+1,415,632
| New | +$91.3M |
|
4
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $53.5M | 5.84% |
+1,213,841
| New | +$53.5M |
|
5
Avantis Real Estate ETF
AVRE
$634M
| $49.3M | 5.38% |
+1,184,284
| New | +$49.3M |
|
6
Avantis International Small Cap Value ETF
AVDV
$11.7B
| $45.7M | 4.98% |
+705,369
| New | +$45.7M |
|
7
Avantis Emerging Markets Value ETF
AVES
$773M
| $34.9M | 3.8% |
+753,552
| New | +$34.9M |
|
8
Apple
AAPL
$3.45T
| $24.2M | 2.64% |
+96,116
| New | +$24.2M |
|
9
Exxon Mobil
XOM
$487B
| $8.54M | 0.93% |
+80,794
| New | +$8.54M |
|
10
Procter & Gamble
PG
$368B
| $8.28M | 0.9% |
+49,560
| New | +$8.28M |
|
11
Home Depot
HD
$405B
| $8.1M | 0.88% |
+20,799
| New | +$8.1M |
|
12
Cisco
CSCO
$274B
| $7.32M | 0.8% |
+123,676
| New | +$7.32M |
|
13
Johnson & Johnson
JNJ
$427B
| $7.24M | 0.79% |
+50,519
| New | +$7.24M |
|
14
Chevron
CVX
$324B
| $6.54M | 0.71% |
+45,682
| New | +$6.54M |
|
15
Honeywell
HON
$139B
| $6.42M | 0.7% |
+28,342
| New | +$6.42M |
|
16
AT&T
T
$209B
| $6.19M | 0.68% |
+273,943
| New | +$6.19M |
|
17
Booking.com
BKNG
$181B
| $6.16M | 0.67% |
+1,234
| New | +$6.16M |
|
18
Philip Morris
PM
$260B
| $5.97M | 0.65% |
+49,766
| New | +$5.97M |
|
19
Union Pacific
UNP
$133B
| $5.82M | 0.64% |
+25,568
| New | +$5.82M |
|
20
Bristol-Myers Squibb
BMY
$96B
| $5.81M | 0.63% |
+103,640
| New | +$5.81M |
|
21
Pfizer
PFE
$141B
| $5.76M | 0.63% |
+218,000
| New | +$5.76M |
|
22
McKesson
MCK
$85.4B
| $5.73M | 0.63% |
+10,043
| New | +$5.73M |
|
23
Lowe's Companies
LOW
$145B
| $5.68M | 0.62% |
+23,040
| New | +$5.68M |
|
24
Gilead Sciences
GILD
$140B
| $5.44M | 0.59% |
+59,150
| New | +$5.44M |
|
25
3M
MMM
$82.8B
| $5.44M | 0.59% |
+42,096
| New | +$5.44M |
|